NCT00098501View on ClinicalTrials.gov

CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

October 31, 2007

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

pelitinib

DRUG

temsirolimus

Given PO

Trial Locations (1)

55905

Mayo Clinic, Rochester

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00098501 - CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter